Tissue factor upregulation in the BALF of COVID-19 patients has also been observed at the RNA level using both single cell and bulk RNA-sequencing, and the observed increase correlated with severity (FitzGerald et al., 2021). The gene discussed is F3; the disease is COVID-19.